Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 483980, 6 pages
http://dx.doi.org/10.1155/2015/483980
Research Article

Protective Effect of Artemisia asiatica Extract and Its Active Compound Eupatilin against Cisplatin-Induced Renal Damage

1College of Korean Medicine, Gachon University, Seongnam 461-701, Republic of Korea
2Department of Surgery, University of Ulsan College of Medicine, Gangneung Asan Hospital, Gangneung 210-711, Republic of Korea
3Department of Life and Nanopharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 130-701, Republic of Korea
4Natural Products Research Center, Korea Institute of Science and Technology, Gangneung 210-340, Republic of Korea
5School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea
6Department of Pathology, University of Ulsan College of Medicine, Gangneung Asan Hospital, Gangneung 210-711, Republic of Korea

Received 13 April 2015; Accepted 14 June 2015

Academic Editor: Avni Sali

Copyright © 2015 Jun Yeon Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. H. Hanigan and P. Devarajan, “Cisplatin nephrotoxicity: molecular mechanisms,” Cancer Therapy, vol. 1, pp. 47–61, 2003. View at Google Scholar
  2. J. Li, K. Jiang, X. Qiu et al., “Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer,” BMB Reports, vol. 47, no. 1, pp. 33–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. I. Leibbrandt, G. H. I. Wolfgang, A. L. Metz, A. A. Ozobia, and J. R. Haskins, “Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells,” Kidney International, vol. 48, no. 3, pp. 761–770, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Lieberthal, V. Triaca, and J. Levine, “Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis,” The American Journal of Physiology, vol. 270, no. 4, pp. F700–F708, 1996. View at Google Scholar · View at Scopus
  5. A. H. Lau, “Apoptosis induced by cisplatin nephrotoxic injury,” Kidney International, vol. 56, no. 4, pp. 1295–1298, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. H. R. Brady, B. C. Kone, M. E. Stromski, M. L. Zeidel, G. Giebisch, and S. R. Gullans, “Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules,” The American Journal of Physiology—Renal Fluid and Electrolyte Physiology, vol. 258, no. 5, pp. F1181–F1187, 1990. View at Google Scholar · View at Scopus
  7. H. Huang, L. Zhu, B. R. Reid, G. P. Drobny, and P. B. Hopkins, “Solution structure of a cisplatin-induced DNA interstrand cross-link,” Science, vol. 270, no. 5243, pp. 1842–1845, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Jiang, X. Liao, and P. Li, “Experimental study on apoptosis and Apo-1 expression of buccal carcinoma cell (BCC) induced by cisplatin,” Huaxi Kouqiang Yixue Zazhi, vol. 17, no. 4, pp. 300–303, 1999. View at Google Scholar · View at Scopus
  9. H. Zhou, T. Miyaji, A. Kato, Y. Fujigaki, K. Sano, and A. Hishida, “Attenuation of cisplatin-induced acute renal failure is associated with less apoptotic cell death,” Journal of Laboratory and Clinical Medicine, vol. 134, no. 6, pp. 649–658, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Shiraishi, L. M. Curtis, L. Truong et al., “Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis,” The American Journal of Physiology—Renal Physiology, vol. 278, no. 5, pp. F726–F736, 2000. View at Google Scholar · View at Scopus
  11. H. N. Varzi, S. Esmailzadeh, H. Morovvati, R. Avizeh, A. Shahriari, and M. E. Givi, “Effect of silymarin and vitamin E on gentamicin-induced nephrotoxicity in dogs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 30, no. 5, pp. 477–481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Harlalka, C. Patil, and M. Patil, “Protective effect of Kalanchoe pinnata pers. (Crassulaceae) on gentamicin-induced nephrotoxicity in rats,” Indian Journal of Pharmacology, vol. 39, no. 4, pp. 201–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Jeong, W. M. Hwang, C. H. Yoon, and Y. K. Kim, “Salviae radix extract prevents cisplatin-induced acute renal failure in rabbits,” Nephron, vol. 88, no. 3, pp. 241–246, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Y. Oh, G. J. Ahn, S. M. Choi, B. O. Ahn, and W. B. Kim, “Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract,” World Journal of Gastroenterology, vol. 11, no. 47, pp. 7450–7456, 2005. View at Google Scholar · View at Scopus
  15. B. K. Ryu, B. O. Ahn, T. Y. Oh, S. H. Kim, W. B. Kim, and E. B. Lee, “Studies on protective effect of DA-9601, artemisia asiatica extract, on acetaminophen- and CCl4-induced liver damage in rats,” Archives of Pharmacal Research, vol. 21, no. 5, pp. 508–513, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. K.-B. Hahm, J.-H. Kim, B.-M. You et al., “Induction of apoptosis with an extract of Artemisia asiatica attenuates the severity of cerulein-induced pancreatitis in rats,” Pancreas, vol. 17, no. 2, pp. 153–157, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. H. J. Seo, K. K. Park, S. S. Han et al., “Inhibitory effects of the standardized extract (DA-9601) of Artemisia asiatica Nakai on phorbol ester-induced ornithine decarboxylase activity, papilloma formation, cyclooxygenase-2 expression, inducible nitric oxide synthase expression and nuclear transcription factor κB activation in mouse skin,” International Journal of Cancer, vol. 100, no. 4, pp. 456–462, 2002. View at Publisher · View at Google Scholar
  18. T. Y. Oh, J. S. Lee, B. O. Ahn et al., “Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats,” Gut, vol. 49, no. 3, pp. 364–371, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Y. Seol, M. H. Kim, J. S. Rew, and M. G. Choi, “A phase III clinical trial of Stillen(TM) for erosive gastritis,” Korean Journal of Gastrointestinal Endoscopy, vol. 28, no. 5, pp. 230–236, 2004. View at Google Scholar
  20. E. B. Lee, S. A. Cheon, E. S. Lee et al., “General pharmacology of artemisia extract powder, DA-9601,” Journal of Applied Pharmacology, vol. 4, no. 2, pp. 174–183, 1996. View at Google Scholar
  21. T. Y. Oh, B. O. Ahn, J. I. Ko et al., “Studies on protective effect of da-9601, an artemisiae herba extract, against ethanol-induced gastric mucosal damage and its mechanism,” Biomolecules & Therapeutics, vol. 5, no. 2, pp. 202–210, 1997. View at Google Scholar
  22. E.-J. Choi, H.-M. Oh, H. Wee et al., “Eupatilin exhibits a novel anti-tumor activity through the induction of cell cycle arrest and differentiation of gastric carcinoma AGS cells,” Differentiation, vol. 77, no. 4, pp. 412–423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-H. Cheong, S. Y. Hong, Y. Zheng, and S. H. Noh, “Eupatilin inhibits gastric cancer cell growth by blocking STAT3-mediated VEGF expression,” Journal of Gastric Cancer, vol. 11, no. 1, pp. 16–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Yokozawa, E. J. Cho, Y. Hara, and K. Kitani, “Antioxidative activity of green tea treated with radical initiator 2,2′-azobis(2-amidinopropane) dihydrochloride,” Journal of Agricultural and Food Chemistry, vol. 48, no. 10, pp. 5068–5073, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-Y. Pan, Y. Qu, J.-K. Zhang, T. G. Kang, and D.-Q. Dou, “Antioxidant activity of ginseng cultivated under mountainous forest with different growing years,” Journal of Ginseng Research, vol. 37, no. 3, pp. 355–360, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. K. I. Song, J. Y. Park, S. Lee et al., “Protective effect of tetrahydrocurcumin against cisplatin-induced renal damage: in vitro and in vivo studies,” Planta Medica, vol. 81, no. 4, pp. 286–291, 2015. View at Publisher · View at Google Scholar
  27. A. Dubey, J. W. Min, H. J. Koo et al., “Anticancer potency and multidrug-resistant studies of self-assembled arene-ruthenium metallarectangles,” Chemistry—A European Journal, vol. 19, no. 35, pp. 11622–11628, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. K. S. Kang, J. Ham, Y.-J. Kim, J. H. Park, E.-J. Cho, and N. Yamabe, “Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism,” Journal of Ginseng Research, vol. 37, no. 4, pp. 379–388, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Dolado, A. Swat, N. Ajenjo, G. De Vita, A. Cuadrado, and A. R. Nebreda, “p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis,” Cancer Cell, vol. 11, no. 2, pp. 191–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Wang and J. Yi, “Cancer cell killing via ROS: to increase or decrease, that is the question,” Cancer Biology & Therapy, vol. 7, no. 12, pp. 1875–1884, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Zhang, Y. Sun, Z. Yuan et al., “Heat shock protein 90β inhibits apoptosis of intestinal epithelial cells induced by hypoxia through stabilizing phosphorylated Akt,” BMB Reports, vol. 46, no. 1, pp. 47–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Ramachandiran, Q. Huang, J. Dong, S. S. Lau, and T. J. Monks, “Mitogen-activated protein kinases contribute to reactive oxygen species-induced cell death in renal proximal tubule epithelial cells,” Chemical Research in Toxicology, vol. 15, no. 12, pp. 1635–1642, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-S. Lee, G.-S. Lee, S.-H. Kim, H.-K. Kim, D.-H. Suk, and D.-S. Lee, “Anti-oxidizing effect of the dichloromethane and hexane fractions from Orostachys japonicus in LPS-stimulated RAW 264.7 cells via upregulation of Nrf2 expression and activation of MAPK signaling pathway,” BMB Reports, vol. 47, no. 2, pp. 98–103, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. I. H. Bae, S. W. Kang, S. H. Yoon, and H.-D. Um, “Cellular components involved in the cell death induced by cisplatin in the absence of p53 activation,” Oncology Reports, vol. 15, no. 5, pp. 1175–1180, 2006. View at Google Scholar · View at Scopus
  35. I. Sánchez-Pérez, M. Martínez-Gomariz, D. Williams, S. M. Keyse, and R. Perona, “CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin,” Oncogene, vol. 19, no. 45, pp. 5142–5152, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. J. W. Pippin, R. Durvasula, A. Petermann, K. Hiromura, W. G. Couser, and S. J. Shankland, “DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes,” The Journal of Clinical Investigation, vol. 111, no. 6, pp. 877–885, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. K. S. Kang, W. Lee, Y. Jung et al., “Protective effect of esculin on streptozotocin-induced diabetic renal damage in mice,” Journal of Agricultural and Food Chemistry, vol. 62, no. 9, pp. 2069–2076, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Ueda, G. P. Kaushal, and S. V. Shah, “Apoptotic mechanisms in acute renal failure,” American Journal of Medicine, vol. 108, no. 5, pp. 403–415, 2000. View at Publisher · View at Google Scholar · View at Scopus